Nonprofit Global Oncology, Inc (GO) has announced that Donna Barry has been appointed to be its first Executive Director, effective immediately.
U.S. and global investments in improving cancer outcomes are minimal—in 2011, only 1.2% of total development assistance for global health was focused on noncommunicable diseases. According to the World Health Organization (WHO), available low-cost cancer control options could avert approximately one-third of cancer deaths worldwide. But these interventions are unavailable for many people in the world, especially those living in low-resource countries. GO is committed to addressing this need.
Ms. Barry brings to GO her broad-ranging expertise obtained during a 25-year career spanning medicine, global health, advocacy, and policy. She will spearhead the work of GO’s Board of Directors and Advisors to leverage GO’s extensive community of volunteers, collaborators, and supporters across academia, government and industry to set and execute a global strategy for making the best in cancer care available to patients in low- and middle-income countries. In her role, Ms. Barry will also be responsible for managing and expanding GO’s operations, domestic and international.
Ms. Barry comes to GO from the Center for American Progress (CAP) in Washington, DC, where she was Director of the Women’s Health and Rights Program. Prior to CAP, Ms. Barry was the Advocacy and Policy Director at Partners in Health. She remains active in the health field as a policy fellow at the National Academies of Practice and a member of the American Public Health Association.
About Global Oncology
GO was founded by Ami Bhatt, MD, PhD, Assistant Professor of Medicine and of Genetics at Stanford University School of Medicine and Director of Global Oncology, Center for Innovation in Global Health; and Franklin Huang, MD, PhD, Instructor in Medicine at Harvard Medical School and Dana-Farber Cancer Institute and postdoctoral scholar at the Broad Institute. They founded GO to help address the enormous unmet need for cancer diagnosis, treatment, and palliative care in low- and middle-resource countries. ■